-
Cangene Corporation was a
biopharmaceutical company based in Winnipeg, Manitoba, Canada. It was
founded in 1984 and
specialized in hyperimmunes, contract...
- (trade name BAT), made by
Emergent BioSolutions Canada Inc. (formerly
Cangene Corporation), is a licensed,
commercially available botulism anti-toxin...
- (IVIG). [WinRho SDF is an anti-D manufactured,
distributed and
marketed by
Cangene in the US.
There is a
black box
warning on
WinRho SDF due to the risk of...
-
Apotex owned 61% of
Cangene Corp., a Winnipeg-based
biopharmaceutical company,
according to
Cangene's 2007
annual report.
Cangene's business focuses are...
- (1916–????)
Cambridge Antibody Technology (1989–2007)
CancerVax (1998–2005)
Cangene (1984–2014)
CareFusion (2009–2015)
Celltech (1980–2004)
Cephalon (1987–2011)...
- 102
doses of Raxiba****ab. 10,000
doses of
anthrax immune globulin from
Cangene,
which also
treats anthrax. By 2010, the
supply was down to 7,327 doses...
- that
lasted up to 8 hours.
Episil oral
liquid is
marketed in the US by
Cangene. In a 2012
randomized controlled pilot study involving pediatric patients...
- plasma. The
others are
Canadian Blood Services (CBS), Hema-Quebec and
Cangene, now
owned by
ProMetic Life
Sciences Inc.
Canadian Plasma Resources is...
- bacteria.
BARDA also
supported the
development of the
antitoxins Anthrasil of
Cangene (March 2015 FDA approval) and
Anthim of
Elusys Therapeutics (March 2016...
- the year 2020. The
company purchased Winnipeg, Manitoba's
Cangene Corporation in 2013.
Cangene's leading product is WinRho,
which treats the
blood disease...
